Noticias de IONS_US

Mercado

Noticias del mercado

Últimas noticias sobre IONS_US — 420 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: IONS_US ✕ 420 resultados
08/07/2026 IONS_US — Quartr ES ← EN
Ionis Pharmaceuticals (IONS) Jefferies London Healthcare Conference 2025 Resumen

Resumen de la Conferencia Jefferies London Healthcare 2025 de Ionis Pharmaceuticals (IONS), que combina transcripciones, diapositivas y documentos relacionados.

07/07/2026 IONS_US — Investing.com ES ← EN
Formulario 144 IONIS PHARMACEUTICALS INC Para: 7 de julio Por Investing.com

Form 144 IONIS PHARMACEUTICALS INC For: 7 July By Investing.com

07/07/2026 IONS_US — Investing.com ES ← EN
Formulario 144 IONIS PHARMACEUTICALS INC Para: 7 de julio Por Investing.com

Form 144 IONIS PHARMACEUTICALS INC For: 7 July By Investing.com

07/07/2026 IONS_US — Investing.com ES ← EN
Formulario 144 IONIS PHARMACEUTICALS INC Para: 7 de julio Por Investing.com

Form 144 IONIS PHARMACEUTICALS INC For: 7 July By Investing.com

07/07/2026 IONS_US — Seeking Alpha
Novartis’ Pipeline Building Continues, Pelacarsen Readout Coming Soon (NYSE:NVS)
07/07/2026 IONS_US — Clinical Trials Arena
Ionis Pharmaceuticals concludes REVEAL study pivotal cohort enrolment
07/07/2026 IONS_US — Stock Titan
IONIS PHARMACEUTICALS INC SEC Filing (Jul 7, 2026)
07/07/2026 IONS_US — Stock Titan
Holly Kordasiewicz files Form 144 to sell 60,846 shares (IONS)
07/07/2026 IONS_US — Stock Titan
IONS (Nasdaq: IONS) brokered notice to sell 67,386 shares
07/07/2026 IONS_US — Yahoo Finance
IONS Completes Enrollment in Pivotal Cohort of Angelman Syndrome Study

Ionis completa la inscripción en la cohorte pediátrica fundamental de su estudio REVEAL de fase III, avanzando obudanersen hacia posibles presentaciones regulatorias.

06/07/2026 IONS_US — Investing.com ES ← EN
Formulario 4 Ionis Pharmaceuticals Inc Para: 6 de julio Por Investing.com

Form 4 Ionis Pharmaceuticals Inc For: 6 July By Investing.com

06/07/2026 IONS_US — Investing.com Nigeria
Form 4 Ionis Pharmaceuticals Inc For: 6 July By Investing.com
06/07/2026 IONS_US — Investing.com ES ← EN
Formulario 4 Ionis Pharmaceuticals Inc Para: 6 de julio Por Investing.com

Form 4 Ionis Pharmaceuticals Inc For: 6 July By Investing.com

06/07/2026 IONS_US — Stock Titan
Ionis (NASDAQ: IONS) director receives 2026 RSU and stock option grants
06/07/2026 IONS_US — ChartMill
IONS News | IONIS PHARMACEUTICALS INC (NASDAQ:IONS)
06/07/2026 IONS_US — DirectorsTalk Interviews ES ← EN
Análisis de acciones de Ionis Pharmaceuticals, Inc. (IONS): explorando una ventaja potencial del 29,48 % en el ámbito biotecnológico

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 29.48% Potential Upside in the Biotech Sphere

06/07/2026 IONS_US — BioSpace
Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome
06/07/2026 IONS_US — Stock Titan
Ionis (NASDAQ: IONS) director exercises options, sells 11,518 shares under plan
06/07/2026 IONS_US — Stock Titan
Ionis (NASDAQ: IONS) director receives $400K-capped RSUs and options grant
06/07/2026 IONS_US — Stock Titan
Ionis (NASDAQ: IONS) director granted RSUs and stock options as 2026 pay

Página 19 de 21